Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

Kidney Int. 2008 May;73(9):994-1007. doi: 10.1038/ Epub 2008 Feb 13.


Cisplatin is one of the most widely used and most potent chemotherapy drugs. However, side effects in normal tissues and organs, notably nephrotoxicity in the kidneys, limit the use of cisplatin and related platinum-based therapeutics. Recent research has shed significant new lights on the mechanism of cisplatin nephrotoxicity, especially on the signaling pathways leading to tubular cell death and inflammation. Renoprotective approaches are being discovered, but the protective effects are mostly partial, suggesting the need for combinatorial strategies. Importantly, it is unclear whether these approaches would limit the anticancer effects of cisplatin in tumors. Examination of tumor-bearing animals and identification of novel renoprotective strategies that do not diminish the anticancer efficacy of cisplatin are essential to the development of clinically applicable interventions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Apoptosis
  • Cisplatin / adverse effects*
  • Cisplatin / metabolism
  • Humans
  • Inflammation / chemically induced
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / prevention & control*
  • Oxidative Stress
  • Signal Transduction


  • Cisplatin